AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,172 | +1.8% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,134 | +19.3% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,789 | -20.9% | 30,000 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $2,261 | -99.8% | 30,000 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $1,302,000 | -9.1% | 30,000 | -25.0% | 0.00% | 0.0% |
| Q2 2022 | $1,432,000 | +149.5% | 40,000 | +178.7% | 0.00% | +300.0% |
| Q1 2022 | $574,000 | +21.6% | 14,350 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $472,000 | +10.0% | 13,050 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $429,000 | -50.5% | 12,650 | 0.0% | 0.00% | -66.7% |
| Q2 2021 | $867,000 | +24.2% | 12,650 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $698,000 | -32.2% | 12,650 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,029,000 | +8.7% | 12,650 | -4.9% | 0.00% | 0.0% |
| Q3 2020 | $947,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |